期刊文献+

4-[(2-四氢吡喃)氧]苯酚的合成 被引量:6

Synthesis of 4-[(Tetrahydro-2H-pyran-2-yl)oxy] phenol
下载PDF
导出
摘要 4-[(2-四氢吡喃)氧]苯酚(脱氧熊果苷)是一种有效的酪氨酸酶抑制剂,可作为化妆品添加剂来实现美白功能。今以对苯二酚为原料,经过对苯二酚单苄醚化、另一酚羟基四氢吡喃醚化、加氢脱苄基等步骤合成4-[(2-四氢吡喃)氧]苯酚。该路线中二氢吡喃保护羟基采用了吡啶对甲苯磺酸盐(PPTS)作催化剂,获得了满意的结果。各步反应比较适宜的工艺条件(反应温度,反应时间,摩尔收率)分别为,对苯二酚单苄醚化:75℃,3h,36%;另一酚羟基四氢吡喃醚化:30℃,5h,80%;加氢:30℃,24h,79%。产物熔点与文献报道相符,并通过1H-NMR确认了脱氧熊果苷的结构。 4-[(Tetrahydro-2U-pyran-2-yl)oxy]phenol is an effective tyrosinase inhibitor, which could be used as cosmetic additive to achieve lightening skin. A synthetic rout of 4-[(Tetrahydro-2U-pyran-2-yl)oxy]phenol was designed by using hydroquinone as raw material and via hydroquinone monobenzyl etherification, another phenolic hydroxyl tetrahydropyran etherification and debenzylation by catalytic hydrogenation. Comparing with methods reported in literatures, the second step can get a good result with PPTS as catalyst. The suitable reaction conditions (temperature, time and molar yield) of the proposed rout were found as follows: 75℃, 3 h and 36% for hydroquinone monobenzyl etherification; 30℃, 5 h and 80% for another phenolic hydroxyl tetrahydropyran etherification; 30℃, 24 h and 79% for hydrotreating debenzylimine. The melting point of the obtained product was found to be in conformity with those reported in literatures, and the structure of the title compound was confirmed by 1H-NMR.
出处 《高校化学工程学报》 EI CAS CSCD 北大核心 2010年第1期117-121,共5页 Journal of Chemical Engineering of Chinese Universities
关键词 酪氨酸酶抑制剂 脱氧熊果苷 吡啶对甲苯磺酸盐 合成 tyrosinase inhibitor deoxyArbutin PPTS synthesis
  • 相关文献

参考文献11

  • 1龚盛昭,杨卓如,程江.肉桂酸抑制酪氨酸酶催化反应的动力学研究[J].高校化学工程学报,2007,21(2):345-349. 被引量:19
  • 2Chawla Smita.Effect of Deoxyarbutin and its Second-generation Derivatives on Melanocyte Viability and Function[D].Cincinnati,OH,USA:University of Cincinnati.2006.
  • 3The Protector & Gamble Company.Process for making monoacetals of hydroquinone[P].WO Patent:9,523,778,1995-08-09.
  • 4The Protector & Gamble Company.Skin lightening compositions[P].WO Patent:9,523,780,1995-08-09.
  • 5Boissy R E,Visscher M,de Long M A.DeoxyArbutin:a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency[J].Experimental Dermatology,2005,14(8):601-608.
  • 6Hamed S H,Sriwiriyanont P,de Long M A et al.Comparative efficacy and safety of deoxyarbutin,a new tyrosinase-inhibiting agent[J].Journal of Cosmetic Science,2006,57(4):291-308.
  • 7He G,Wang J,Ma D.Highly convergent route to cyclopeptide alkaloids.Total synthesis of ziziphine N[J].Organic Letters,2007,9(7):1367-1369.
  • 8Chopa A B,Silbestri G F,Lockhart M T.Strategies for the synthesis of bi-and triarylic materials starting from commercially available phenols[J].Journal of Organometallic Chemistry,2005,690(17):3865-3877.
  • 9Li L J,Zhu L Z,Zhang X Y et al.Convenient tetrahydropyranylation of alcohols and phenols by catalytic ferric sulfate hydrate(Fe2(SO4)3·xH2O)[J].Canadian Journal of Chemistry,2005,83(8):1120-1123.
  • 10Girindus AG.Synthesis of hydroquinone derivatives[P].WO Patent:2006,134,124,2006-12-21.

二级参考文献4

共引文献18

同被引文献52

  • 1房军,杜顺晶,金银龙.熊果苷在化妆品中应用的研究进展[J].卫生研究,2009,38(1):111-113. 被引量:20
  • 2丁大鹏,马文丽,郑文岭.酪氨酸酶抑制剂的研究进展[J].实用医学杂志,2005,21(12):1364-1366. 被引量:27
  • 3陈清西,宋康康.酪氨酸酶的研究进展[J].厦门大学学报(自然科学版),2006,45(5):731-737. 被引量:110
  • 4龚盛昭,杨卓如,程江.肉桂酸抑制酪氨酸酶催化反应的动力学研究[J].高校化学工程学报,2007,21(2):345-349. 被引量:19
  • 5邓菊香,王祖元.苯丙氨酸的生产现状与发展前景[J].安徽化工,2007,33(4):1-3. 被引量:11
  • 6Zimetbaum P. Amiodarone for atrial fibrillation [J]. N Engl J Med, 2007, 356: 935-941.
  • 7Friederich P, Pfizenmayer H. The novel Kv1.5 channel blocker vernakaJant for successful treatment of new-onset atrial fibrillation in a critically ill abdominal surgical patient [J]. Br J Anaesth. 2011, 107(4): 644-645.
  • 8Bronis K, Metaxa S, Koulouris S, et al. Vernakalant: review of a novel atrial selective antiarrhythmic agent and its place in current treatment of atrial fibrillation [J]. Hospital Chronicles, 2012, 7(3): 171-181.
  • 9Li J J, Johnson D S. Modern drug synthesis [M]. Canada: A John Wiley & Sons, Inc., Press, 2010: 159-173.
  • 10Roy D, Pratt C M, Torp-Pedersen C. et al. Vernakalant hydrochloride for rapid conversion of atrial fibrillation : A Phase 3, randomized, placebo-controlled trial [J]. Circulation, 2008, 117: 1518-1525.

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部